다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Vernalis Plc ADS (MM) (VNLS)
Vernalis Plc ADS (MM) (VNLS) 뉴스

VNLS

Vernalis (VNLS)

Vernalis Plc ADS (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VNLS

1

일자	시간	출처	헤드라인	심볼	기업
2006/12/11	16:00	PR Newswire (US)	Vernalis plc Initiates a Phase I Trial of a Promising New Approach to Treating Obesity and Related Disorders - Including Type II	NASDAQ:VNLS
2006/11/21	16:00	PR Newswire (US)	Vernalis plc to Present at the 18th Annual Piper Jaffray Healthcare Conference in New York on November 30, 2006	NASDAQ:VNLS	Vernalis Plc ADS (MM)
2006/11/20	16:00	PR Newswire (US)	Vernalis plc Announces Progress on Its Oncology Hsp90 Programme	NASDAQ:VNLS
2006/11/02	16:00	PR Newswire (US)	Vernalis to Present at Cowen and Company 7th Annual Global Health Care Conference	NASDAQ:VNLS
2006/09/20	22:31	PR Newswire (US)	Vernalis plc to Present at UBS Global Life Sciences Conference on September 26, 2006	NASDAQ:VNLS	Vernalis Plc ADS (MM)
2006/09/20	19:30	PR Newswire (US)	Vernalis plc Announces FDA Acceptance for Filing of Frova(R) for Short-Term Prevention of Menstrual Migraine	NASDAQ:VNLS
2006/09/12	16:00	PR Newswire (US)	Vernalis Plc: Interim Results for the Six Months Ended 30 June 2006	NASDAQ:VNLS
2006/07/20	07:00	PR Newswire (US)	Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of Men	NASDAQ:VNLS	Vernalis Plc ADS (MM)
2006/07/20	07:00	PR Newswire (US)	Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of Men	NASDAQ:VNLS
2006/06/19	20:00	PR Newswire (US)	Vernalis plc to Present at Investor Conferences During June 2006	NASDAQ:VNLS	Vernalis Plc ADS (MM)
2006/05/18	02:00	PR Newswire (US)	Vernalis plc [VNLS] CEO to Ring the NASDAQ Stock Market Closing Bell	NASDAQ:VNLS	Vernalis Plc ADS (MM)
2006/05/15	16:00	PR Newswire (US)	Vernalis plc to Ring the NASDAQ Closing Bell on May 18, 2006	NASDAQ:VNLS
2006/05/08	16:00	PR Newswire (US)	Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual Migraine	NASDAQ:VNLS
2004/07/15	07:50	PR Newswire (US)	Endo Licenses Rights from Vernalis to Market Acute Migraine Treatment Frova(TM)	NASDAQ:VNLS
2004/03/30	21:00	PR Newswire (US)	Vernalis Regains Control of North American Rights To Frovatriptan From Elan	NASDAQ:VNLS	Vernalis Plc ADS (MM)
2004/03/30	21:00	PR Newswire (US)	Vernalis plc: Preliminary Results for the Eight Months Ended 31 December 2003	NASDAQ:VNLS

검색 관련기사 보기:NASDAQ:VNLS

1

BNP Paribas Issuance

Azelis Group NV (PK)

Universal Auction Program

VanEck Investments

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관